Proteoglycans and neoplasia.
There is a growing realization that the whole tumor cell-matrix complex must be investigated in order to fully understand the process of cancer growth and metastasis. Proteoglycans are intrinsic constituents of the cell surface, extracellular matrix, and basement membrane, three logistically and functionally important structures involved in most cellular interactions. Proteoglycans influence the behavior of normal and malignant cells by virtue of their expanded configuration, polyanionic nature and, most of all, by their ability to interact with a variety of cellular products. Consequently, they have been implicated in a number of biological processes including proliferation, recognition, adhesion, and migration. They can serve as links between the extracellular and intracellular environment and thus transduce key biological signals. They can act as receptors for interstitial collagens and other matrix proteins and thus contribute to the organization of pericellular matrix. During neoplastic development there is a profound structural rearrangement of these macromolecules at both the plasma membrane and the pericellular level. Qualitative and quantitative abnormalities in proteoglycan metabolism may contribute to the establishment of some well-known neoplastic properties, including lack of cohesiveness, abnormal assembly of extracellular matrix, abnormal growth, and invasion. The present work will focus on recent advances in our understanding of these complex macromolecules and on some of the alterations associated with the neoplastic phenotype, and will then attempt to elucidate some of the mechanisms regulating these changes.
Iozzo
R V
RV
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.
D001688:Biological Products / Q000502:physiology; D002455:Cell Division; D002471:Cell Transformation, Neoplastic; D016207:Cytokines; D006025:Glycosaminoglycans / Q000378:metabolism; D006497:Heparan Sulfate / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000201:enzymology / Q000503:physiopathology*; D011509:Proteoglycans / Q000378:metabolism / Q000502:physiology*
D001688:Biological Products; D016207:Cytokines; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D011509:Proteoglycans